ASSEMBLY BIOSCIENCES, INC.
Company Stats
- Market Cap
- $478.3M
- as of Sep 30, 2026
- Shares Outstanding
- 20.4M
- Free Float
- 34.3%
Income Statement
- Revenue
- $72.3M
- Operating Income
- -$12.1M
- Net Income
- -$6.1M
- EBITDA
- -$12.0M
- FCF Margin, 3Y Avg
- 25.9%
- FCF Margin, Worst Year
- -179.3%
Cash Flow
- Free Cash Flow
- -$41.2M
- FCF Yield
- -8.6%
- Owner FCF Yield
- -9.6%
Balance Sheet
- Cash & Equivalents
- $58.5M
Returns & Capital
- SBC, 3Y Avg
- $4.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $72.3M | -$41.2M | -56.9% |
| FY2024 | $28.5M | -$51.1M | -179.3% |
| FY2023 | $7.2M | $22.5M | 313.9% |
| FY2022 | $0 | -$84.6M | — |
| FY2021 | $6.3M | -$96.5M | -1542.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges